Key Details
Price
$2.34Annual EPS
-$7.00Annual ROE
-139.12%Beta
1.16Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 10, 2023Recent annual earnings:
Mar 14, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Oct 09, 2024Analyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with DWTX included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Dogwood Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024
DWTX
globenewswire.com31 October 2024
ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced today that it will report third quarter 2024 financial results on Thursday, November 7, 2024 before the open of the financial markets. Management will also host a webcast and conference call on November 7, 2024 at 8:30 a.m. ET to discuss the results and provide a corporate update.
FAQ
- What is the primary business of Dogwood Therapeutics?
- What is the ticker symbol for Dogwood Therapeutics?
- Does Dogwood Therapeutics pay dividends?
- What sector is Dogwood Therapeutics in?
- What industry is Dogwood Therapeutics in?
- What country is Dogwood Therapeutics based in?
- Is Dogwood Therapeutics in the S&P 500?
- Is Dogwood Therapeutics in the NASDAQ 100?
- Is Dogwood Therapeutics in the Dow Jones?
- When was Dogwood Therapeutics's last earnings report?
- When does Dogwood Therapeutics report earnings?
- Should I buy Dogwood Therapeutics stock now?
What is the primary business of Dogwood Therapeutics?
Dogwood Therapeutics is a biotechnology company focused on developing innovative treatments for neurological disorders using advanced drug delivery systems.
What is the ticker symbol for Dogwood Therapeutics?
The ticker symbol for Dogwood Therapeutics is NASDAQ:DWTX
Does Dogwood Therapeutics pay dividends?
No, Dogwood Therapeutics does not pay dividends
What sector is Dogwood Therapeutics in?
Dogwood Therapeutics is in the Healthcare sector
What industry is Dogwood Therapeutics in?
Dogwood Therapeutics is in the Biotechnology industry
What country is Dogwood Therapeutics based in?
Dogwood Therapeutics is headquartered in United States
Is Dogwood Therapeutics in the S&P 500?
No, Dogwood Therapeutics is not included in the S&P 500 index
Is Dogwood Therapeutics in the NASDAQ 100?
No, Dogwood Therapeutics is not included in the NASDAQ 100 index
Is Dogwood Therapeutics in the Dow Jones?
No, Dogwood Therapeutics is not included in the Dow Jones index
When was Dogwood Therapeutics's last earnings report?
Dogwood Therapeutics's most recent earnings report was on 10 August 2023
When does Dogwood Therapeutics report earnings?
The date for Dogwood Therapeutics's next earnings report has not been announced yet
Should I buy Dogwood Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions